Home » Topics » BioWorld Science

BioWorld Science
RSS

Vasomax enters pivotal trials

Nov. 15, 1996

PKC inhibitors from Lilly for various therapeutic indications

Nov. 15, 1996

Wyeth-Ayerst withdraws diabetes drug from markets worldwide

Nov. 15, 1996

Imidazoline compound reported as lead for oral hypoglycemic agents

Nov. 15, 1996

Takeda describes potential antidiabetic agents

Nov. 15, 1996

Hyperparathyroidism Rx from NPS effective in dialysis patients

Nov. 15, 1996

Promising clinical results for lamivudine in hepatitis

Nov. 15, 1996

Provir effective in acute diarrhea

Nov. 15, 1996

Therapeutic effect of Lilly antioxidant demonstrated in rat model of IBD

Nov. 15, 1996

Roberts to license Lilly gastrointestinal compounds

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...